Weight loss support before IVF could boost pregnancy chances – and reduce the need for treatment
Women with obesity who are planning a pregnancy are already advised that losing weight can improve their chances of conceiving. Our research suggests that structured weight loss support may also improve outcomes for those seeking IVF.
Our study analysed data from 12 international trials involving 1,921 women living with obesity, all planning IVF. It compared those offered a weight loss programme before IVF with those receiving standard care, which typically does not include such support.
Women who took part in a weight loss programme had a 21% higher chance of becoming pregnant overall – whether naturally or through IVF. The biggest difference was in natural conceptions: the likelihood of getting pregnant without IVF rose by 47%, meaning some women avoided fertility treatment altogether.
However, despite these higher pregnancy rates and no increase in miscarriage risk, there was no clear evidence of an effect on live birth rates. This may be because many of the included studies didn't track live birth outcomes – even though this is the result that matters most to patients.
IVF access paradox
In the UK, publicly funded IVF is restricted to women with a BMI under 30. Similar weight-based eligibility rules exist in many other countries. These policies disproportionately affect women from more deprived backgrounds and some ethnic groups, who are more likely to be living with obesity.
The paradox is clear: women with obesity are more likely to need IVF, but less likely to be eligible for it.
Some can afford private weight loss programmes to meet the BMI requirement. Others resort to unproven or unsafe methods to lose weight quickly, risking their health in order to access fertility care.
Our research findings suggest that offering structured weight loss programmes to women with obesity who are otherwise ineligible for IVF could help more women become pregnant – and in some cases avoid IVF altogether.
This approach could also make fertility treatment more equitable. Since the cost of weight loss support is relatively low compared with IVF, including it in the treatment pathway might offer better value for healthcare providers.
Weight loss options before IVF
The most effective non-surgical option for significant weight loss is a class of medications called GLP-1 receptor agonists – such as Wegovy or Mounjaro – which have been shown to lead to substantial weight reduction.
However, these drugs should not be used during pregnancy, while trying to conceive, or while breastfeeding, as there's little safety data in humans – and animal studies suggest potential harm to foetal development. Anyone who becomes pregnant while taking GLP-1 drugs should stop immediately and consult a healthcare professional.
For women planning to conceive soon, there are other safe and effective options, including structured support groups and low-energy diet programmes. The problem is that such services are not offered as part of standard IVF care.
While some NHS weight management programmes exist, access is limited, waiting lists can be long, and most are aimed at people with obesity-related health conditions rather than those seeking fertility treatment. In many other countries, insurance coverage for weight loss support is similarly patchy, meaning these services must often be funded privately – a cost that can put them out of reach for those who could benefit most.
The message from this research is clear: targeted, supportive weight loss programmes before IVF don't just improve pregnancy chances – they could also reduce the need for IVF, promote fairer access to fertility treatment, and save healthcare resources. The challenge now is making sure they're available to everyone who needs them, not just those who can afford to pay.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
The authors do not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
World's ‘oldest baby': what a 30-year-old embryo tells us about the future of fertility
A baby born in the US has made headlines for a surprising reason: they came from an embryo that had been frozen for more than 30 years — setting a new world record. The embryo was created and stored in 1994, back when Bill Clinton was US president and the internet, email and mobile phones were still in their infancy. Now, decades later, that embryo has become a living child. But how is this possible – and what does it mean for the future of fertility treatment? Freezing embryos is a common and effective part of in vitro fertilisation (IVF). During IVF, multiple eggs are fertilised, and any unused embryos can be frozen and stored for future use. Globally, thousands of embryos are placed in long-term storage each year – and as the demand for fertility treatment grows, so too does the number of embryos in storage. But once a person or couple finishes treatment, the question of what to do with unused embryos can become complicated. As this case in the US illustrates, families and circumstances change. Relationships may end. People may change their minds. And yet, many feel conflicted about allowing embryos to 'perish' (the term used when frozen embryos are removed from storage, thawed and not used), especially after investing significant emotional, physical and financial resources in their creation. As a result, many continue to pay storage fees for years – sometimes decades – after their treatment has ended. Embryo donation One option for those with unused embryos is to donate them. Typically, this is coordinated through the fertility clinic. But in this record-breaking case, the embryos were donated through a US Christian organisation called Snowflakes, which allows donors to choose the recipients. The donor – now a woman in her 60s – wanted a say in where the embryos went because any resulting children would be full genetic siblings to her 30-year-old daughter. In many countries, donor-conceived people are now entitled to information about their donors. But rarely does this involve embryos frozen for decades – raising the possibility of a future connection between the child, their parents and the donor family, including a half-sibling born 30 years earlier. In the US, there's no legal limit on how long embryos (or sperm and eggs) can be stored. In the UK, the maximum storage limit was recently extended to 55 years, enabling a similar situation: someone could be conceived from an embryo stored for decades, and the donor may be elderly – or even deceased – by the time contact is made. Read more: What remains unclear is how these wide age gaps between donor and child – or between donor-conceived siblings – might affect how people relate to one another. It's an area that remains largely unexplored. Finding genetic relatives As direct-to-consumer DNA testing becomes increasingly common, more donor-conceived people are turning to services like 23andMe and to find genetic relatives outside of regulated routes. These commercial tests allow users to upload a sample and receive a list of people they may be related to, including potential donors or donor siblings. With longer embryo storage periods possible, it's likely that people will use these platforms to make contact with genetic relatives across many years, bypassing formal donor registries and regulated systems. In this US case, the embryo donation took place within the same country. But that's not always the case. With the globalisation of fertility treatment, including international travel and the cross-border shipment of frozen sperm, eggs and embryos, it's increasingly common for people who are genetically related to live in different countries. A 2024 Netflix documentary about sperm donation highlighted this issue, showing how a single donor fathered children in multiple countries, prompting calls for better regulation of international donor limits. One of the most intriguing – and underexplored – questions is how people born from decades-old embryos will come to understand their origins. While research on donor-conceived families suggests that they typically function well, the idea of being 'frozen in time' for 30 years is unique. It introduces a temporal disconnect between conception and birth that may feel uncanny or dislocating. Donor-conceived people are often curious about their genetic background – but being born from an embryo created before the internet or mobile phones adds another layer to this. It could influence how people make sense of their identity, family connections, and even their place in history, especially if their genetic siblings or donors are decades older, or deceased. The long gap between fertilisation and birth raises profound questions not just about biology, but about belonging, narrative, and what it means to be from a particular time. With rapid advances in reproductive technology, it's likely this won't be the last record-breaking case. As techniques improve and cultural boundaries around family and parenthood continue to evolve, we'll see more questions arise: about identity, genetics and what it really means to be part of a family. This article is republished from The Conversation under a Creative Commons license. Read the original article. Nicky Hudson receives funding from the UK Economic and Social Research Council. She is a member of the UK NICE Guideline Committee on fertility treatment, a working group member for the Nuffield Council on Bioethics' project on Reviewing the 14-day rule, a member of the British Fertility Society's Law, Policy and Ethics group and an advisory board member for the Fertility Alliance.
Yahoo
2 hours ago
- Yahoo
Menopause and brain fog: why lifestyle medicine could make a difference
By 2030, an estimated 47 million women worldwide will enter menopause each year. The transition through menopause can last several years and brings with it a host of physical, mental and brain changes. One of the most distressing symptoms reported by women is 'brain fog'. This umbrella term refers to difficulties with memory, concentration and mental clarity. Women may find themselves forgetting words, names or appointments, or misplacing items. While these symptoms can be alarming, they usually resolve after menopause and are not a sign of dementia. Hormonal fluctuations, particularly declining oestrogen levels, are a key driver of cognitive changes during the menopause transition. But it's not just hormones. Hot flushes, night sweats, poor sleep and low mood all contribute to cognitive difficulties. The good news? Many of the contributing factors are modifiable. That's where lifestyle medicine comes in. Lifestyle medicine is an evidence-based approach that uses lifestyle interventions to prevent and manage chronic conditions such as heart disease, diabetes and dementia. It focuses on six pillars: sleep, physical activity, nutrition, stress management, social connection and avoidance of harmful substances. These same pillars can also support cognitive health during menopause. Sleep is an underestimated factor in brain health — it is essential for memory consolidation and brain repair. Yet one in three women going through menopause experience significant sleep disturbance. Hot flashes, anxiety, and hormonal changes can all disrupt sleep, creating a vicious cycle that worsens brain fog. Improving sleep hygiene can help. This includes avoiding caffeine late in the day, reducing screen time before bed, keeping a consistent sleep schedule and maintaining a cool bedroom. Physical activity during the day – especially outside in the morning – also supports better sleep. Physical activity is one of the most powerful tools for brain health. It improves blood flow to the brain, reduces inflammation and increases the size of the hippocampus (the brain's memory centre). It also helps regulate mood, improve sleep and support cardiovascular and metabolic health. For menopausal women, it has the added benefit of improving bone health, sexual function and maintaining a healthy weight. The World Health Organization recommends at least 150–300 minutes of moderate-intensity aerobic activity per week, plus two sessions of muscle-strengthening exercises. Even brisk walking can make a difference. Stress can make it difficult to think clearly and chronic stress may accelerate brain ageing through chronically elevated cortisol levels. Menopause can be a stressful time, especially when cognitive changes affect sleep, confidence and daily functioning. Mindfulness, yoga, tai chi and breathing exercises can help reduce stress and improve focus. Cognitive behavioural therapy (CBT), a form of talking therapy, is also effective in addressing negative thought patterns and improving coping strategies. Finding a hobby that brings joy or a sense of 'flow' can also be a powerful stress reliever. What we eat plays a crucial role in brain health. The Mediterranean diet — rich in vegetables, fruits, whole grains, legumes, nuts, olive oil and fish — has been linked to better memory and reduced risk of cognitive decline. Omega-3 fatty acids, found in fatty fish and flaxseeds, are particularly beneficial for brain function. Avoiding ultra-processed foods, added sugars and trans fats can help reduce inflammation and stabilise energy levels. Social connection is a powerful yet often overlooked pillar of lifestyle medicine that has substantial effects on physical, mental and brain health. During menopause, women may feel less able to participate in social activities and experience increased isolation or changes in relationships, which can negatively affect mood and cognition. Strong social ties stimulate the brain, support emotional regulation, and buffer against stress. Quality matters more than quantity. Regular check-ins with friends, joining a club, volunteering, or even brief positive interactions can all make a difference. Alcohol and other substances can have a circular effect on sleep, mood, and cognition. While alcohol may initially feel relaxing, it disrupts sleep quality and can worsen anxiety and memory issues. Reducing alcohol and avoiding tobacco and recreational drugs can improve sleep, mood and cognitive clarity. If cutting back feels difficult, seeking support from a healthcare professional or support group can be a helpful first step. Making lifestyle changes can feel overwhelming, especially when you're already feeling tired or stressed. Financial pressures or personal circumstances can make lifestyle changes feel out of reach. Start small. Make just one change in one pillar, such as sticking to a regular bedtime or adding a short daily walk, and build from there. Small, consistent steps can make a big difference to clearing brain fog. Menopausal brain fog is real, but it's also manageable. By focusing on the six pillars of lifestyle medicine, women can take proactive steps to support their cognitive health and overall wellbeing during this important life transition. This article is republished from The Conversation under a Creative Commons license. Read the original article. Maria Pertl receives research funding from the Irish Cancer Society and the National Cancer Control Programme. She is a committee member of the Irish Society of Lifestyle Medicine. Lisa Mellon co-founded the Irish Society for Lifestyle Medicine.
Bloomberg
3 hours ago
- Bloomberg
Fertility Startup Gameto Raises $44 Million to Test Egg-Freezing Therapy in US
Gameto Inc., a biotech company working on stem-cell therapies for women's health, has raised $44 million in venture capital to help fund a clinical trial for its product that aims to improve the egg-freezing experience. The funding round, led by Overwater Ventures, will let Gameto bring its Fertilo therapy closer to US Food and Drug Administration approval. The technique, which uses stem cells that have been engineered into ovarian support cells, is intended to free patients from the grueling two weeks of injections that prompt ovaries to make enough eggs during fertility treatment. In a Phase 3 trial, patients are only given three days of injections, after which their eggs are extracted and matured by the engineered cells.
